Towards a non-living vaccine against Shigella flexneri: From the inactivation procedure to protection studies

Methods

Volumn 60, Issue 3, 2013, Pages 264-268

  Camacho, A I ^a   Souza Reboucas J ^a   Irache, J M ^a   Gamazo, C ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Outer membrane vesicles; Safety; Shigella; Subunit vaccine

Indexed keywords

AZIRIDINE; SHIGELLA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; IMMUNOGENICITY; MOUSE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLOSIS; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; AZIRIDINES; BACTERIAL OUTER MEMBRANE PROTEINS; DYSENTERY, BACILLARY; MICE; MICE, INBRED BALB C; SHIGELLA FLEXNERI; SHIGELLA VACCINES; SURVIVAL ANALYSIS; VACCINATION; VACCINES, INACTIVATED;

MUS; SHIGELLA; SHIGELLA FLEXNERI;

EID: 84878856922     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2012.09.008     Document Type: Article

References (52)

1. Bopp C.A., Brenner F.W., Fields P.I., et al. and Salmonella. Manual of Clinical Microbiology 2003, 654-671. ASM Press, Washington. eighth ed. E.J. Baron, J.H. Jorgensen (Eds.).
2. Schroeder G.N., Hilbi H. Clin. Microbiol. Rev. 2008, 21:134-156.
3. World Health Organization, Statistic Quarterly Reported Disease Prevention and Control, Geneva, 1986.
4. Biosafety in Microbiological and Biomedical Laboratories (BMBL), fifth ed., 2012.
5. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., Adak G.K., Levine M.M. Bull. World Health Organ. 1999, 77:651-666.
6. Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., Sztein M.B. Nat. Rev. Microbiol. 2007, 5:540-553.
7. Kweon M.N. Curr. Opin. Infect. Dis. 2008, 21:313-318.
8. Kaminski R.W., Oaks E.V. Expert Rev. Vaccines 2009, 8:1693-1704.
9. Walker D., Campbell D. J. Clin. Pathol. 1999, 52:415-418.
10. Parsot C., Sansonetti P.J. Curr. Top. Microbiol. Immunol. 1996, 209:25-42.
11. Brown F. Dev. Biol. Stand. 1991, 75:37-41.
12. Doel T.R. Virus Res. 2003, 91:81-99.
13. Martin S.S., Bakken R.R., Lind C.M., Garcia P., Jenkins E., Glass P.J., Parker M.D., Hart M.K., Fine D.L. Vaccine 2010, 28:1031-1040.
14. von Koenig C.H., Finger H., Hof H. Nature 1982, 297:233-234.
15. Lauvau G., Vijh S., Kong P., Horng T., Kerksiek K., Serbina N., Tuma R.A., Pamer E.G. Science 2001, 294:1735-1739.
16. Blackburn N.K., Besselaar T.G. J. Virol. Methods 1991, 33:367-374.
17. Chakrabarti M.K., Bhattacharya J., Bhattacharya M.K., Nair G.B., Bhattacharya S.K., Mahalanabis D. Acta Paediatr. 1999, 88:161-165.
18. Mukhopadhaya A., Mahalanabis D., Khanam J., Chakrabarti M.K. Vaccine 2003, 21:3043-3050.
19. Osorio M., Bray M.D., Walker R.I. Vaccine 2007, 25:1581-1592.
20. McKenzie R., Walker R.I., Nabors G.S., Van Der Verg L.L., Carpenter C., Gomes G., Forbes E., Tian J.H., Yang H.H., Pace J.L., Jackson W.J., Bourgeois A.L. Vaccine 2006, 24:3735-3745.
21. Formal S.B., Labrec E.H., Palmer A., Falkow S. J. Bacteriol. 1965, 90:63-68.
22. Bahnemann H.G. Vaccine 1990, 8:299-303.
23. Kulp A., Kuehn M.J. Annu. Rev. Microbiol. 2010, 64:163-184.
24. de Kleijn E.D., de Groot R., Labadie J., Lafeber A.B., van den Dobbelsteen G., van Alphen L., van Dijken H., Kuipers B., van Omme G.W., Wala M., Juttmann R., Rumke H.C. Vaccine 2000, 18:1456-1466.
25. Danzig L. Pediatr. Infect. Dis. J. 2004, 23:S285-S292.
26. van de Waterbeemd B., Streefland M., van der Ley P., Zomer B., van Dijken H., Martens D., Wijffels R., van der Pol L. Vaccine 2010, 28:4810-4816.
27. Ellis T.N., Leiman S.A., Kuehn M.J. Infect. Immun. 2010, 78:3822-3831.
28. Schild S., Nelson E.J., Bishop A.L., Camilli A. Infect. Immun. 2009, 77:472-484.
29. Alaniz R.C., Deatherage B.L., Lara J.C., Cookson B.T. J. Immunol. 2007, 179:7692-7701.
30. McConnell M.J., Rumbo C., Bou G., Pachon J. Vaccine 2011, 29:5705-5710.
31. Camacho A.I., de Souza J., Sanchez-Gomez S., Pardo-Ros M., Irache J.M., Gamazo C. Vaccine 2011, 29:8222-8229.
32. Bahnemann H.G. Arch. Virol. 1975, 47:47-56.
33. Bahrani F.K., Sansonetti P.J., Parsot C. Infect. Immun. 1997, 65:4005-4010.
34. Marolda C.L., Lahiry P., Vines E., Saldias S., Valvano M.A. Methods Mol. Biol. 2006, 347:237-252.
35. Lee C.H., Tsai C.M. Anal. Biochem. 1999, 267:161-168.
36. Diaz R., Bosseray N. Microbiol. Esp. 1974, 27:1-14.
37. Kosek M., Bern C., Guerrant R.L. Bull. World Health Organ. 2003, 81:197-204.
38. Mukhopadhaya A., Mahalanabis D., Chakrabarti M.K. Vaccine 2006, 24:6028-6036.
39. Biswas A., Banerjee P., Mukherjee G., Biswas T. Mol. Immunol. 2007, 44:812-820.
40. M.S. Favero, W.W. Bond, Sterilization and preservation, in: Lea, Febiger (Eds.), Chemical Disinfection of Medical and Surgical Materials, Philadelphia, 1991, pp. 617-641.
41. Lindskog M., Rockberg J., Uhlen M., Sterky F. Biotechniques 2005, 38:723-727.
42. Cryz S.J., Furer E., Germanier R. Infect. Immun. 1982, 38:21-26.
43. Preuss T., Kamstrup S., Kyvsgaard N.C., Nansen P., Miller A., Lei J.C. Clin. Diagn. Lab. Immunol. 1997, 4:504-508.
44. Mowat G.N., Masters R.C., Prince M.J. Arch. Gesamte Virusforsch. 1973, 41:365-370.
45. Turbyfill K.R., Hartman A.B., Oaks E.V. Infect. Immun. 2000, 68:6624-6632.
46. Cam P.D., Pal T., Lindberg A.A. J. Clin. Microbiol. 1993, 31:454-457.
47. Darboe N., Kenjale R., Picking W.L., Picking W.D., Middaugh C.R. Protein Sci. 2006, 15:543-552.
48. Caro M.R., Ortega N., Buendia A.J., Gallego M.C., del Río L., Cuello F., Salinas J. Vaccine 2003, 21:3126-3136.
49. Kadurugamuwa J.L., Beveridge T.J. Antimicrob. Agents Chemother. 1998, 42:1476-1483.
50. Martinez-Becerra F.J., Kissmann J.M., Díaz-McNair J., Choudhari S.P., Quick A.M., Mellado-Sanchez G., Clements J.D., Pasetti M.F., Picking W.L. Infect. Immun. 2012, 80:1222-1231.
51. Kesty N.C., Kuehn M.J. J. Biol. Chem. 2004, 279:2069-2076.
52. Sanders H., Feavers I.M. Expert Rev. Vaccines 2011, 10:323-334.